Julie is responsible for shaping and implementing the Boston IC strategy for programs and relationships across eastern North America. This includes innovative programs and deployment of business models that bring together all aspects of the innovation community including academia, venture, foundations and startups to create leveraged outreach and funding opportunities that can help expand the portfolio-building efforts and provide frameworks for seeding and de-risking technologies and assets. Julie has nearly 15 years of experience working in the Boston innovation community including three years at J&J, where she served as the Director of External Alliances for the World Without Disease Accelerator and Lung Cancer Initiatives and previously, the Janssen Human Microbiome Institute. Prior to J&J, Julie held various Program and Alliance Management roles in the Boston ecosystem including leading the Corporate Alliances team at Harvard’s Office of Technology Development. Julie began her biopharmaceutical career at Merck Research Laboratories, Boston, in Drug Metabolism and Pharmacokinetics. Julie holds an MBA from Boston University and BS from Villanova University.